Dominik Gary is a trained biotechnologist and specializes in the development of new immunological or molecular biological diagnostics in the field of human or veterinary medicine. He completed his studies at the University of Applied Sciences Jena. Since 2014, he has been working at fzmb GmbH, Research Center for Medical Technology and Biotechnology (Germany). The fzmb GmbH has extensive experience in immunochemistry, biomedicine and bioanalytics. Founded in 1994 by biotechnologists, engineers and medical specialists, the ISO-certified company today develops and produces innovative, high-quality diagnostic products for laboratories and point-of-care applications. Since 2018, Dominik has served as Chief Development Officer at INTER-ARRAY, the microarray division of fzmb GmbH. INTER-ARRAY offers a comprehensive range of services related to the microarray platform and develops its own products specifically in the area of multidrug-resistant bacteria. Their genotyping kits enable the molecular characterization of more than 700 different methicillin-resistant Staphylococcus aureus clones based on DNA microarray technology.